Hiteck licenses neurotrophic keratitis eye drop HT006 to Visara
October 15, 2026 | 15:58
Biotechnology company Hiteck granted Visara exclusive international licensing rights outside Greater China to develop and commercialise investigational Nerve Growth Factor eye drop candidate HT006.2.2.
Mobile Version